Skip to main content

stock

SAEN · Genenta Science S.p.A.

Follow SAEN free

Price

Loading the SAEN chart…

Chart by TradingView

The business

What the company does and what it reports, from its SEC filings.

What it is

No 10-K on file. Funds and foreign issuers don't file one.

Sector
Life Sciences (SEC office)
Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Headquarters
Milan, L6
Incorporated in
Italy
Exchange
Nasdaq
Fractional shares
No
Listed options
No
Filer category
Non-accelerated filer<br>Emerging growth company
Formerly
Genenta Science S.r.l. (until 2021)
Shares outstanding
23,432,183 as of Dec 31, 2025 (XBRL frame CY2025Q4I)
Filer (SEC EDGAR)
EDGAR filing index

Key stats

Valuation and the ratios that use the live price are free with an account.

Start free to see this

Deep value

NCAV
—
NCAV per share
—
NNWC
—
NNWC per share
—

Expectations

Free cash flow, FY2025
-6.88M EUR
Free cash growth, last 5 years
—
Revenue growth, last 5 years
—

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-29.9%
ROA
-20.5%

Health

Current ratio
14.2x
Debt/equity
—

Fiscal year to Dec 31, 2025; balance sheet at Dec 31, 2025.

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

No quarterly results reported by SEC for this filer.

Cash
5.53M EUR
Debt
—
Net cash
—
Current assets
29.98M EUR
Current liabilities
2.12M EUR
Working capital
27.86M EUR
Total liabilities (not reported by this company)
—Total liabilities: unreported by this company.
Assets
31.89M EUR
Equity
21.84M EUR

Balance as of Dec 31, 2025.

SEC data as of Nov 17, 2026

Earnings moves

No results filings

SAEN has filed no 8-K results release since Oct 6, 2025.

Ten years

No revenue reported in these years.

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
Dec 31, 2025—-6.60M EUR-6.53M EUR-6.88M EUR
Dec 31, 2024—-9.76M EUR-8.91M EUR-6.24M EUR
Dec 31, 2023—-11.73M EUR-11.65M EUR-11.22M EUR
Dec 31, 2022—-11.04M EUR-8.48M EUR-7.45M EUR
Dec 31, 2021—-5.69M EUR-5.53M EUR-6.97M EUR
Dec 31, 2020—-5.59M EUR-5.59M EUR-6.07M EUR
Dec 31, 2019—-4.62M EUR-4.60M EUR—

What it filed

Material events and 5% ownership filings from the last year.

Company filings

1 offering filing in 12 months

5% owners ()

Owners and trading

Insider, politician and fund moves, short interest, and the volume traded off the exchange.

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

Short interest

Hard to borrow: Alpaca will not lend it for shorting

Off-exchange short volume, 20 days

21.9%

Through Nov 17, 2026

Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.

Short interest and short volume: FINRA

Off-exchange and dark pools

No off-exchange data

FINRA has no off-exchange data for SAEN yet.

Members see

  • Signals: which strategies fired on SAEN, and the evidence behind each
  • Options positioning: the levels dealers are hedged around
  • Technicals: trend and momentum readings
  • Earnings moves: how the price moved after each report
  • News: stories counted once across outlets
Start free to see these

Comments · 0

No comments yet.

Be the first to say something about SAEN.

nakagai

Signals on SAEN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Follow SAEN free

Not financial advice. Read the terms that govern posting here.